These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1758851)

  • 1. [Improving ambulatory services for children in the foci of tuberculosis with special reference to the factors of increased risk of infection].
    Bobchenok AP
    Probl Tuberk; 1991; (8):23-5. PubMed ID: 1758851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis in children and adolescents in orphanage and boarding schools and optimization of its prevention].
    Mitinskaia LA; Ivanova ES; Kufakova GA
    Probl Tuberk; 1993; (5):2-4. PubMed ID: 8295878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical course of tuberculosis in young children, vaccinated and non-vaccinated with BCG vaccine].
    Korol OI; Odintsov AI; Krivokhizh VN
    Probl Tuberk; 1994; (6):21-4. PubMed ID: 7708640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with latent tuberculosis infection in Mexican American children.
    Young J; O'Connor ME
    Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of tuberculosis vaccines].
    Nechaeva OB; Arenskiĭ VA
    Probl Tuberk; 2001; (1):13-4. PubMed ID: 11337770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contingents of IIIA groups in the dispensary follow-up of children].
    Kozlova AV; Shuravina MG
    Probl Tuberk; 1995; (6):9-10. PubMed ID: 8524777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiologic hazard of various tuberculosis foci].
    Iakovlev NI
    Probl Tuberk; 1989; (4):3-6. PubMed ID: 2734261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis of tuberculosis with BCG vaccine in children from contact and from unknown contact].
    Khadeeva PV; Mikhaleva LV; Morozov IuA
    Probl Tuberk Bolezn Legk; 2005; (1):29-32. PubMed ID: 15801633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research on BCG vaccination.
    ten Dam HG
    Adv Tuberc Res; 1984; 21():79-106. PubMed ID: 6433675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BCG revaccination of school children in circumstances of low incidence of tuberculosis].
    Lebedeva LV; Aksenova VA; Ioramashvili NG; Puchkov KG; Levi DT; Gorovenko LI
    Probl Tuberk; 1992; (1-2):15-8. PubMed ID: 1603781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six years' experience with the discontinuation of BCG vaccination. 1. Risk of tuberculosis infection and disease.
    Trnka L; Danková D; Svandová E
    Tuber Lung Dis; 1993 Jun; 74(3):167-72. PubMed ID: 8369510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan.
    Bowerman RJ
    Int J Tuberc Lung Dis; 2004 Oct; 8(10):1228-33. PubMed ID: 15527155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of tuberculin reactivity in different age groups with and without BCG vaccination].
    Yildirim C; Küçük AI; Ongüt G; Oğünç D; Colak D; Mutlu G
    Mikrobiyol Bul; 2009 Jan; 43(1):27-35. PubMed ID: 19334377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
    Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increasing the effectiveness of preventive measures in the tuberculosis foci].
    Korkina IV; Permiakova ZA
    Probl Tuberk; 1988; (7):68-70. PubMed ID: 3217409
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factors for the onset of and the exacerbation of tuberculosis. 3. Clinical factors for the development and the exacerbation of active tuberculosis. a. Children, young adult].
    Takamatsu I
    Kekkaku; 1999 Oct; 74(10):741-6. PubMed ID: 10565135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculin reactivity and tuberculosis epidemiology in the Pakaanóva (Wari') Indians of Rondônia, south-western Brazilian Amazon.
    Escobar AL; Coimbra CE; Camacho LA; Santos RV
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):45-51. PubMed ID: 14974745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
    Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of tuberculosis].
    Dautzenberg B
    Rev Pneumol Clin; 1994; 50(5):275-9. PubMed ID: 7899762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.